Profile data is unavailable for this security.
About the company
CStone Pharmaceuticals is a China-based investment holding company. Through its subsidiaries, the Company is primarily engaged in development, manufacturing and sales of biopharmaceutical products. Its main products include immuno-oncology drugs and molecularly targeted drugs. The Company conducts its businesses mainly in domestic market.
- Revenue in HKD (TTM)490.40m
- Net income in HKD-152.87m
- Incorporated2015
- Employees164.00
- LocationCStone Pharmaceuticals1000 Zhangheng Road Bldg 25Pudong New DistrictSUZHOU 200072ChinaCHN
- Phone+86 51 287186550
- Websitehttps://www.cstonepharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jacobio Pharmaceuticals Group Co Ltd | 24.91m | -388.74m | 1.29bn | 298.00 | -- | 1.33 | -- | 51.63 | -0.5008 | -0.5008 | 0.0321 | 1.23 | 0.016 | -- | 2.41 | 82,741.46 | -24.89 | -45.76 | -28.66 | -49.30 | 3.45 | -- | -1,560.88 | -372.22 | -- | -- | 0.1794 | -- | -33.66 | -- | 3.43 | -- | 19.18 | -- |
| Mabpharm Ltd | 162.87m | -222.28m | 1.38bn | 297.00 | -- | 11.17 | -- | 8.48 | -0.0539 | -0.0539 | 0.0395 | 0.03 | 0.164 | 0.1937 | 3.26 | 469,376.20 | -22.38 | -21.42 | -31.11 | -27.49 | 86.91 | -- | -136.47 | -486.40 | 0.6836 | -22.44 | 0.679 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
| TOT Biopharm International Co Ltd | 1.05bn | 9.63m | 1.46bn | 572.00 | 142.35 | 1.88 | 21.41 | 1.40 | 0.0133 | 0.0133 | 1.44 | 1.01 | 0.6899 | 2.44 | 6.40 | 1,897,227.00 | 0.6356 | -20.01 | 0.8392 | -25.21 | 72.02 | 74.74 | 0.9212 | -68.53 | 1.63 | 2.98 | 0.3465 | -- | 76.54 | 81.88 | 24.36 | -- | 21.04 | -- |
| Hua Medicine | 117.02m | -282.92m | 1.65bn | 172.00 | -- | -- | -- | 14.07 | -0.2886 | -0.2886 | 0.1194 | -0.0363 | 0.0779 | 1.51 | 3.31 | 661,157.10 | -18.84 | -25.61 | -23.63 | -28.81 | 37.72 | -- | -241.76 | -1,654.70 | 4.64 | -- | 1.14 | -- | 335.31 | -- | -3.80 | -- | 14.07 | -- |
| Qyuns Therapeutics Co Ltd | 48.25m | -453.10m | 1.98bn | 325.00 | -- | 5.02 | -- | 41.10 | -1.93 | -1.93 | 0.219 | 1.78 | -- | -- | -- | 145,775.50 | -- | -- | -- | -- | 84.05 | -- | -976.77 | -- | 1.83 | -29.56 | 0.5795 | -- | -- | -- | -70.28 | -- | -- | -- |
| Frontage Holdings Corp | 2.02bn | 47.47m | 2.18bn | 1.66k | 46.60 | 0.8315 | 6.44 | 1.08 | 0.023 | 0.023 | 0.988 | 1.29 | 0.4701 | 56.23 | 4.58 | 1,150,374.00 | 1.06 | 4.46 | 1.30 | 5.28 | 28.56 | 34.00 | 2.26 | 9.92 | 1.25 | 2.37 | 0.311 | 0.00 | 3.79 | 25.61 | -58.00 | -0.7826 | 40.43 | -- |
| Biocytogen Pharmaceuticals Beijng Co Ltd | 859.97m | -261.91m | 2.40bn | 1.04k | -- | 3.02 | -- | 2.79 | -0.6576 | -0.6576 | 2.16 | 1.99 | 0.3109 | 23.64 | 5.36 | 806,728.50 | -9.47 | -- | -12.44 | -- | 71.97 | -- | -30.46 | -- | 1.33 | -4.18 | 0.436 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
| CStone Pharmaceuticals | 490.40m | -152.87m | 2.56bn | 164.00 | -- | 5.09 | -- | 5.21 | -0.12 | -0.12 | 0.3847 | 0.3912 | 0.2861 | 1.33 | 2.50 | 2,132,195.00 | -8.92 | -54.76 | -16.99 | -81.68 | 70.73 | -- | -31.17 | -301.62 | 1.45 | -- | 0.4171 | -- | -3.64 | -- | 59.32 | -- | 52.42 | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | 404.97k | -402.17m | 2.74bn | 150.00 | -- | 4.25 | -- | 6,772.28 | -1.12 | -1.12 | 0.0011 | 1.72 | -- | -- | -- | 2,792.90 | -- | -- | -- | -- | -- | -- | -99,307.43 | -- | -- | -- | 0.14 | -- | -28.25 | -- | 5.82 | -- | -- | -- |
| Abbisko Cayman Ltd | 534.17m | -17.40m | 3.15bn | 275.00 | -- | 1.41 | 886.04 | 5.89 | -0.0295 | -0.0295 | 0.8225 | 3.27 | 0.2159 | -- | 65.75 | 2,070,417.00 | -0.7034 | -- | -0.733 | -- | 0.00 | -- | -3.26 | -- | -- | -- | 0.0142 | -- | -- | -- | 12.92 | -- | -- | -- |
Data as of Nov 22 2024. Currency figures normalised to CStone Pharmaceuticals's reporting currency: Hong Kong Dollar HKD
1.40%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2024 | 9.09m | 0.71% |
| Templeton Asset Management Ltd.as of 30 Sep 2024 | 8.21m | 0.64% |
| Vanguard Fiduciary Trust Co.as of 31 Aug 2024 | 584.12k | 0.05% |
| SSgA Funds Management, Inc.as of 07 Nov 2024 | 126.50k | 0.01% |
| Ping An Fund Management Co., Ltd.as of 30 Jun 2024 | 0.00 | 0.00% |
| Vanguard Global Advisers LLCas of 30 Sep 2024 | 0.00 | 0.00% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2024 | 0.00 | 0.00% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2024 | 0.00 | 0.00% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 11 Nov 2024Source: FactSet Research Systems Inc.
